Pharmaceutical Business review

Cellectricon designates David Burns as CEO

Burns has held executive management positions at Renishaw Diagnostics, Cyntellect, GE Healthcare, Imaging Research, BioSignal Packard, and Pharmacia / LKB.

Cellectricon chairman Axel Broms said they are looking forward to working with him in formulating and broadening the product offering using the company’s strong IP and technology position.

"David’s experience in both research instruments and service businesses complements Cellectricon’s strategic aim to deliver more value to its customers by offering assay development services based on Cellectricons in-house technology expertise in addition to instrument sales," Broms said.